The team at Fibich, Leebron, Copeland & Briggs is now actively
reviewing cases from those who may have suffered adverse health effects
through the use of popular weight loss drug Qysmia®. Qysmia is gaining
an increasing amount of attention over its potential to cause serious
side effects, including a particularly dreadful skin disease called Stevens-Johnson Syndrome.
Manufactured by the California-based pharmaceutical company Vivus, Qysmia
is a drug for chronic weight management that works by suppressing a user’s
appetite. Although the drug is FDA-approved, it can cause a host of side
effects ranging from eye problems, birth defects, and metabolic acidosis
to suicidal thoughts and seizures.
One of the most serious side effects linked to Qysmia use is Stevens-Johnson
Syndrome (or SJS), a rare skin disease that results in cell death and
causes the layers of the skin to separate. SJS can lead to Toxic Epidermal
Necrolysis (TEN), another skin disorder with seriously damaging effects
including blistering, discoloration, and exfoliation of the skin, hives
and burns, shedding of nails and hair, and in the most serious instances,
even damage to internal organs and loss of eyesight.
Stevens-Johnson Syndrome can cause great pain and permanent scarring and
can in some cases be life threatening. Recovering from such a serious illness can take weeks, months, or even
years, in which costly medical bills can begin to pile up.
You shouldn’t have to suffer for using a dangerous product that has
been marketed as safe for use. If you or a loved one have taken Qysmia
and suffered any kind of adverse side effect, including SJS, your rights
are protected under
product liability law and you can be eligible to claim compensation for your medical care
and pain and suffering.
Fibich, Leebron, Copeland & Briggs are available to review
your case and inform you of your legal options during a